829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin

BACKGROUND: The EnACT trial was a phase 2 randomized clinical trial conducted in Uganda, which evaluated a novel orally delivered lipid nanocrystal (LNC) amphotericin B for treatment of cryptococcal meningitis. Oral LNC amphotericin B applies nanotechnology, which hopes to improve intracellular drug...

Descripción completa

Detalles Bibliográficos
Autores principales: McHale, Thomas, Akampurira, Andrew, Gerlach, Elliot, Atukunda, Mucunguzi, Nicol, Melanie R, Williams, Darlisha A, Meya, David, Boulware, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678681/
http://dx.doi.org/10.1093/ofid/ofad500.874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678681/
http://dx.doi.org/10.1093/ofid/ofad500.874

Ejemplares similares